Elevated levels of the enzyme arginase contribute to vascular eye damage and researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
Elevated levels of the enzyme arginase contribute to vascular eye damage and researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.